Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f75d2603562-trace').style.display = (document.getElementById('cakeErr67f75d2603562-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f75d2603562-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f75d2603562-code').style.display = (document.getElementById('cakeErr67f75d2603562-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f75d2603562-context').style.display = (document.getElementById('cakeErr67f75d2603562-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f75d2603562-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f75d2603562-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 59350,
		&#039;title&#039; =&gt; &#039;ICMR ready to offer Covaxin know-how to other firms -Monika Yadav &#039;,
		&#039;subheading&#039; =&gt; null,
		&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Hindu Business Line&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&amp;rsquo;s Pune-based National Institute of Virology (NIV).&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&amp;ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&amp;rdquo; the source said.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;PSUs brought in&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;
&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 7 May, 2021, https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav&#039;,
		&#039;meta_title&#039; =&gt; &#039;&#039;,
		&#039;meta_keywords&#039; =&gt; &#039;&#039;,
		&#039;meta_description&#039; =&gt; &#039;&#039;,
		&#039;noindex&#039; =&gt; (int) 1,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; null,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 59350,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | ICMR ready to offer Covaxin know-how to other firms -Monika Yadav &#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Technical know how,ICMR,Bharat Biotech,Indian Council of Medical Research,Covid-19 Vaccine,Public Sector Enterprises,Covaxin&#039;,
	&#039;metaDesc&#039; =&gt; &#039;-The Hindu Business Line

It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source

The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Hindu Business Line&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&amp;rsquo;s Pune-based National Institute of Virology (NIV).&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&amp;ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&amp;rdquo; the source said.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;PSUs brought in&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot; title=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 59350,
	&#039;title&#039; =&gt; &#039;ICMR ready to offer Covaxin know-how to other firms -Monika Yadav &#039;,
	&#039;subheading&#039; =&gt; null,
	&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Hindu Business Line&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&amp;rsquo;s Pune-based National Institute of Virology (NIV).&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&amp;ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&amp;rdquo; the source said.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;PSUs brought in&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;
&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 7 May, 2021, https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav&#039;,
	&#039;meta_title&#039; =&gt; &#039;&#039;,
	&#039;meta_keywords&#039; =&gt; &#039;&#039;,
	&#039;meta_description&#039; =&gt; &#039;&#039;,
	&#039;noindex&#039; =&gt; (int) 1,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; null,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 59350
$metaTitle = &#039;LATEST NEWS UPDATES | ICMR ready to offer Covaxin know-how to other firms -Monika Yadav &#039;
$metaKeywords = &#039;Technical know how,ICMR,Bharat Biotech,Indian Council of Medical Research,Covid-19 Vaccine,Public Sector Enterprises,Covaxin&#039;
$metaDesc = &#039;-The Hindu Business Line

It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source

The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract...&#039;
$disp = &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Hindu Business Line&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&amp;rsquo;s Pune-based National Institute of Virology (NIV).&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&amp;ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&amp;rdquo; the source said.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;PSUs brought in&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot; title=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | ICMR ready to offer Covaxin know-how to other firms -Monika Yadav  | Im4change.org</title>
    <meta name="description" content="-The Hindu Business Line

It&rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source

The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>ICMR ready to offer Covaxin know-how to other firms -Monika Yadav </strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <p style="text-align:justify">-The Hindu Business Line</p><p style="text-align:justify"><em>It&rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source</em></p><p style="text-align:justify">The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.</p><p style="text-align:justify">Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&rsquo;s Pune-based National Institute of Virology (NIV).</p><p style="text-align:justify">An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.</p><p style="text-align:justify">&ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&rdquo; the source said.</p><p style="text-align:justify">Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.</p><p style="text-align:justify">As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.</p><p style="text-align:justify"><em>PSUs brought in</em></p><p style="text-align:justify">The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.</p><p style="text-align:justify">Please <a href="https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ" title="https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ">click here</a> to read more.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f75d2603562-trace').style.display = (document.getElementById('cakeErr67f75d2603562-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f75d2603562-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f75d2603562-code').style.display = (document.getElementById('cakeErr67f75d2603562-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f75d2603562-context').style.display = (document.getElementById('cakeErr67f75d2603562-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f75d2603562-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f75d2603562-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 59350,
		&#039;title&#039; =&gt; &#039;ICMR ready to offer Covaxin know-how to other firms -Monika Yadav &#039;,
		&#039;subheading&#039; =&gt; null,
		&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Hindu Business Line&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&amp;rsquo;s Pune-based National Institute of Virology (NIV).&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&amp;ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&amp;rdquo; the source said.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;PSUs brought in&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;
&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 7 May, 2021, https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav&#039;,
		&#039;meta_title&#039; =&gt; &#039;&#039;,
		&#039;meta_keywords&#039; =&gt; &#039;&#039;,
		&#039;meta_description&#039; =&gt; &#039;&#039;,
		&#039;noindex&#039; =&gt; (int) 1,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; null,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 59350,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | ICMR ready to offer Covaxin know-how to other firms -Monika Yadav &#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Technical know how,ICMR,Bharat Biotech,Indian Council of Medical Research,Covid-19 Vaccine,Public Sector Enterprises,Covaxin&#039;,
	&#039;metaDesc&#039; =&gt; &#039;-The Hindu Business Line

It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source

The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Hindu Business Line&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&amp;rsquo;s Pune-based National Institute of Virology (NIV).&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&amp;ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&amp;rdquo; the source said.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;PSUs brought in&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot; title=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 59350,
	&#039;title&#039; =&gt; &#039;ICMR ready to offer Covaxin know-how to other firms -Monika Yadav &#039;,
	&#039;subheading&#039; =&gt; null,
	&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Hindu Business Line&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&amp;rsquo;s Pune-based National Institute of Virology (NIV).&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&amp;ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&amp;rdquo; the source said.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;PSUs brought in&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;
&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 7 May, 2021, https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav&#039;,
	&#039;meta_title&#039; =&gt; &#039;&#039;,
	&#039;meta_keywords&#039; =&gt; &#039;&#039;,
	&#039;meta_description&#039; =&gt; &#039;&#039;,
	&#039;noindex&#039; =&gt; (int) 1,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; null,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 59350
$metaTitle = &#039;LATEST NEWS UPDATES | ICMR ready to offer Covaxin know-how to other firms -Monika Yadav &#039;
$metaKeywords = &#039;Technical know how,ICMR,Bharat Biotech,Indian Council of Medical Research,Covid-19 Vaccine,Public Sector Enterprises,Covaxin&#039;
$metaDesc = &#039;-The Hindu Business Line

It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source

The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract...&#039;
$disp = &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Hindu Business Line&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&amp;rsquo;s Pune-based National Institute of Virology (NIV).&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&amp;ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&amp;rdquo; the source said.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;PSUs brought in&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot; title=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | ICMR ready to offer Covaxin know-how to other firms -Monika Yadav  | Im4change.org</title>
    <meta name="description" content="-The Hindu Business Line

It&rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source

The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>ICMR ready to offer Covaxin know-how to other firms -Monika Yadav </strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <p style="text-align:justify">-The Hindu Business Line</p><p style="text-align:justify"><em>It&rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source</em></p><p style="text-align:justify">The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.</p><p style="text-align:justify">Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&rsquo;s Pune-based National Institute of Virology (NIV).</p><p style="text-align:justify">An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.</p><p style="text-align:justify">&ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&rdquo; the source said.</p><p style="text-align:justify">Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.</p><p style="text-align:justify">As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.</p><p style="text-align:justify"><em>PSUs brought in</em></p><p style="text-align:justify">The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.</p><p style="text-align:justify">Please <a href="https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ" title="https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ">click here</a> to read more.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f75d2603562-trace').style.display = (document.getElementById('cakeErr67f75d2603562-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f75d2603562-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f75d2603562-code').style.display = (document.getElementById('cakeErr67f75d2603562-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f75d2603562-context').style.display = (document.getElementById('cakeErr67f75d2603562-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f75d2603562-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f75d2603562-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 59350,
		&#039;title&#039; =&gt; &#039;ICMR ready to offer Covaxin know-how to other firms -Monika Yadav &#039;,
		&#039;subheading&#039; =&gt; null,
		&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Hindu Business Line&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&amp;rsquo;s Pune-based National Institute of Virology (NIV).&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&amp;ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&amp;rdquo; the source said.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;PSUs brought in&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;
&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 7 May, 2021, https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav&#039;,
		&#039;meta_title&#039; =&gt; &#039;&#039;,
		&#039;meta_keywords&#039; =&gt; &#039;&#039;,
		&#039;meta_description&#039; =&gt; &#039;&#039;,
		&#039;noindex&#039; =&gt; (int) 1,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; null,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 59350,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | ICMR ready to offer Covaxin know-how to other firms -Monika Yadav &#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Technical know how,ICMR,Bharat Biotech,Indian Council of Medical Research,Covid-19 Vaccine,Public Sector Enterprises,Covaxin&#039;,
	&#039;metaDesc&#039; =&gt; &#039;-The Hindu Business Line

It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source

The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Hindu Business Line&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&amp;rsquo;s Pune-based National Institute of Virology (NIV).&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&amp;ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&amp;rdquo; the source said.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;PSUs brought in&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot; title=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 59350,
	&#039;title&#039; =&gt; &#039;ICMR ready to offer Covaxin know-how to other firms -Monika Yadav &#039;,
	&#039;subheading&#039; =&gt; null,
	&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Hindu Business Line&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&amp;rsquo;s Pune-based National Institute of Virology (NIV).&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&amp;ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&amp;rdquo; the source said.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;PSUs brought in&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;
&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 7 May, 2021, https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav&#039;,
	&#039;meta_title&#039; =&gt; &#039;&#039;,
	&#039;meta_keywords&#039; =&gt; &#039;&#039;,
	&#039;meta_description&#039; =&gt; &#039;&#039;,
	&#039;noindex&#039; =&gt; (int) 1,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; null,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 59350
$metaTitle = &#039;LATEST NEWS UPDATES | ICMR ready to offer Covaxin know-how to other firms -Monika Yadav &#039;
$metaKeywords = &#039;Technical know how,ICMR,Bharat Biotech,Indian Council of Medical Research,Covid-19 Vaccine,Public Sector Enterprises,Covaxin&#039;
$metaDesc = &#039;-The Hindu Business Line

It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source

The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract...&#039;
$disp = &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Hindu Business Line&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;It&amp;rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&amp;rsquo;s Pune-based National Institute of Virology (NIV).&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&amp;ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&amp;rdquo; the source said.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;PSUs brought in&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot; title=&quot;https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | ICMR ready to offer Covaxin know-how to other firms -Monika Yadav  | Im4change.org</title>
    <meta name="description" content="-The Hindu Business Line

It&rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source

The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>ICMR ready to offer Covaxin know-how to other firms -Monika Yadav </strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <p style="text-align:justify">-The Hindu Business Line</p><p style="text-align:justify"><em>It&rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source</em></p><p style="text-align:justify">The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.</p><p style="text-align:justify">Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&rsquo;s Pune-based National Institute of Virology (NIV).</p><p style="text-align:justify">An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.</p><p style="text-align:justify">&ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&rdquo; the source said.</p><p style="text-align:justify">Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.</p><p style="text-align:justify">As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.</p><p style="text-align:justify"><em>PSUs brought in</em></p><p style="text-align:justify">The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.</p><p style="text-align:justify">Please <a href="https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ" title="https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ">click here</a> to read more.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 59350,
		'title' => 'ICMR ready to offer Covaxin know-how to other firms -Monika Yadav ',
		'subheading' => null,
		'description' => '<p style="text-align:justify">-The Hindu Business Line</p>

<p style="text-align:justify"><em>It&rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source</em></p>

<p style="text-align:justify">The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.</p>

<p style="text-align:justify">Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&rsquo;s Pune-based National Institute of Virology (NIV).</p>

<p style="text-align:justify">An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.</p>

<p style="text-align:justify">&ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&rdquo; the source said.</p>

<p style="text-align:justify">Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.</p>

<p style="text-align:justify">As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.</p>

<p style="text-align:justify"><em>PSUs brought in</em></p>

<p style="text-align:justify">The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.</p>

<p style="text-align:justify">Please <a href="https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ">click here</a> to read more.</p>
',
		'credit_writer' => 'The Hindu Business Line, 7 May, 2021, https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav',
		'meta_title' => '',
		'meta_keywords' => '',
		'meta_description' => '',
		'noindex' => (int) 1,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => null,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 59350,
	'metaTitle' => 'LATEST NEWS UPDATES | ICMR ready to offer Covaxin know-how to other firms -Monika Yadav ',
	'metaKeywords' => 'Technical know how,ICMR,Bharat Biotech,Indian Council of Medical Research,Covid-19 Vaccine,Public Sector Enterprises,Covaxin',
	'metaDesc' => '-The Hindu Business Line

It&rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source

The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract...',
	'disp' => '<p style="text-align:justify">-The Hindu Business Line</p><p style="text-align:justify"><em>It&rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source</em></p><p style="text-align:justify">The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.</p><p style="text-align:justify">Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&rsquo;s Pune-based National Institute of Virology (NIV).</p><p style="text-align:justify">An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.</p><p style="text-align:justify">&ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&rdquo; the source said.</p><p style="text-align:justify">Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.</p><p style="text-align:justify">As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.</p><p style="text-align:justify"><em>PSUs brought in</em></p><p style="text-align:justify">The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.</p><p style="text-align:justify">Please <a href="https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ" title="https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ">click here</a> to read more.</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 59350,
	'title' => 'ICMR ready to offer Covaxin know-how to other firms -Monika Yadav ',
	'subheading' => null,
	'description' => '<p style="text-align:justify">-The Hindu Business Line</p>

<p style="text-align:justify"><em>It&rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source</em></p>

<p style="text-align:justify">The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.</p>

<p style="text-align:justify">Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&rsquo;s Pune-based National Institute of Virology (NIV).</p>

<p style="text-align:justify">An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.</p>

<p style="text-align:justify">&ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&rdquo; the source said.</p>

<p style="text-align:justify">Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.</p>

<p style="text-align:justify">As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.</p>

<p style="text-align:justify"><em>PSUs brought in</em></p>

<p style="text-align:justify">The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.</p>

<p style="text-align:justify">Please <a href="https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ">click here</a> to read more.</p>
',
	'credit_writer' => 'The Hindu Business Line, 7 May, 2021, https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'icmr-ready-to-offer-covaxin-know-how-to-other-firms-monika-yadav',
	'meta_title' => '',
	'meta_keywords' => '',
	'meta_description' => '',
	'noindex' => (int) 1,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => null,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {},
		(int) 5 => object(Cake\ORM\Entity) {},
		(int) 6 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 59350
$metaTitle = 'LATEST NEWS UPDATES | ICMR ready to offer Covaxin know-how to other firms -Monika Yadav '
$metaKeywords = 'Technical know how,ICMR,Bharat Biotech,Indian Council of Medical Research,Covid-19 Vaccine,Public Sector Enterprises,Covaxin'
$metaDesc = '-The Hindu Business Line

It&rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source

The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract...'
$disp = '<p style="text-align:justify">-The Hindu Business Line</p><p style="text-align:justify"><em>It&rsquo;s only an open-ended deal with co-developer Bharat Biotech, says top source</em></p><p style="text-align:justify">The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.</p><p style="text-align:justify">Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR&rsquo;s Pune-based National Institute of Virology (NIV).</p><p style="text-align:justify">An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.</p><p style="text-align:justify">&ldquo;The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,&rdquo; the source said.</p><p style="text-align:justify">Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.</p><p style="text-align:justify">As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.</p><p style="text-align:justify"><em>PSUs brought in</em></p><p style="text-align:justify">The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.</p><p style="text-align:justify">Please <a href="https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ" title="https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ">click here</a> to read more.</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

ICMR ready to offer Covaxin know-how to other firms -Monika Yadav

-The Hindu Business Line It’s only an open-ended deal with co-developer Bharat Biotech, says top source The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended. Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR’s Pune-based National Institute of Virology (NIV). An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin. “The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,” the source said. Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others. As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand. PSUs brought in The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin. Please click here to read more.